EP1125914A1 — Process for separating and purifying eicosapentaenoic acid or its ester
Assigned to Nisshin Pharma Inc · Expires 2001-08-22 · 25y expired
What this patent protects
Eicosapentaenoic acid or its ester is separated and purified from a mixture containing a highly unsaturated fatty acid or its ester effectively at low cost by a process, which comprises developing the mixture by a mixed solvent of an ether solvent and a hydrocarbon solvent, using…
USPTO Abstract
Eicosapentaenoic acid or its ester is separated and purified from a mixture containing a highly unsaturated fatty acid or its ester effectively at low cost by a process, which comprises developing the mixture by a mixed solvent of an ether solvent and a hydrocarbon solvent, using a column filled with a silica gel having a particle diameter of 1-100 micrometers.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.